Dr. Mark Louis Manwaring, MD

Dr. Manwaring practices at Ascension Saint Thomas Rutherford in Murfreesboro, Tennessee, part of Ascension Health Alliance.

Dr. Manwaring's NPI, 1912107277, was assigned on July 24, 2007. Dr. Manwaring graduated from Jacobs School of Medicine and Biomedical Sciences in 2004. Dr. Manwaring's North Carolina license number on file is 2006-01186.

Dr. Manwaring's primary practice is Ascension Saint Thomas Rutherford, at 1700 Medical Center Parkway, Murfreesboro, TN 37129 in Rutherford County. The practice phone is (615) 396-4100.

Dr. Manwaring's primary practice is Ascension Saint Thomas Rutherford in Murfreesboro, Tennessee, part of Ascension Health Alliance. The medical group on file is Ascension Saint Thomas Medical Partners. Dmand AI also links Dr. Manwaring to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manwaring practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Manwaring's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Manwaring is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Manwaring's licenses on file in 3 states: North Carolina, Tennessee and Ohio.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Manwaring treats.

CMS data shows 250 Medicare services from Dr. Manwaring across 10 procedure codes in 2024, for 182 Medicare patients. Medicare paid $29,152 for them.

CMS counts 182 Medicare patients who saw Dr. Manwaring in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Manwaring's median patient age at 58, with 55% women.

In 2024, Dr. Manwaring wrote 305 Medicare Part D claims for 157 patients. 89% of them were for generic drugs. CMS names the drug for 243 of them, across 4 drugs with 11 or more claims each, at $4,775 in total drug cost. In 2023, CMS named 187 claims across 4 drugs.

Dr. Manwaring accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of colonoscopy by Dr. Manwaring, more than 58% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Manwaring, published from 2007 to 2017. 2015 was the busiest year, with 4. The most frequent topics are Colonic Neoplasms, Laparoscopy and Operative Time. Dr. Manwaring has published most often in Surg Endosc. Dr. Manwaring's most frequent co-authors are Kevin Richard Kasten, MD, Konstantinos Spaniolas, MD and Megan Elaine Sippey, MD.

CMS Open Payments shows 37 general payments to Dr. Manwaring from 9 drug and device companies from 2016 to 2022. Travel and lodging make up the largest share, 48% of the total. Intuitive Surgical, Inc. paid the most, $3,600.

Dmand AI lists 1 award for Dr. Manwaring.

Dr. Manwaring graduated from Jacobs School of Medicine and Biomedical Sciences in 2004. Dr. Manwaring is a member of ACS, ASCRS and SLS.

Dr. Manwaring is in network with 16 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.